BusinessOtonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing LossBy Nasdaq OMXJan 26, 2016, 12:05 PM UTC
BusinessOtonomy Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesBy Nasdaq OMXJan 12, 2016, 2:27 PM UTC
BusinessOtonomy to Present at J.P. Morgan Healthcare ConferenceBy Nasdaq OMXJan 8, 2016, 12:00 PM UTC
